Rapidly Progressive Glomerulonephritis: A Single-Center Experience
暂无分享,去创建一个
G. Şahin | S. Apaydın | F. Aker | G. Gümrükçü | Ö. Can | Günal Bilek | Süleyman Baş | Ali Kaan Güren
[1] S. El-Sayegh,et al. Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis , 2015, BioMed research international.
[2] N. Ozkayar,et al. Prognostic factors in crescentic glomerulonephritis: a single-center experience. , 2015, Iranian journal of kidney diseases.
[3] R. Singh,et al. Clinicopathologic spectrum of crescentic glomerulonephritis: a hospital-based study. , 2014, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[4] C. Stegeman,et al. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[5] Ľ. Podracká,et al. [Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis)]. , 2013, Vnitrni lekarstvi.
[6] L. Harper,et al. Complications of long-term therapy for ANCA-associated systemic vasculitis , 2012, Nature Reviews Nephrology.
[7] H. Rupprecht,et al. ANCA-associated vasculitis with renal involvement: an outcome analysis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] C. Zeng,et al. Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients. , 2003, Chinese medical journal.
[9] R. Westendorp,et al. Lymphocyte Count and Mortality Risk in Older Persons. The Leiden 85‐Plus Study , 2003, Journal of the American Geriatrics Society.
[10] L. Guillevin,et al. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. , 2001, Rheumatology.
[11] C. Kallenberg,et al. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. , 1998, Journal of the American Society of Nephrology : JASN.
[12] R. Falk,et al. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. , 1996, Journal of the American Society of Nephrology : JASN.
[13] E. Ritz,et al. Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. , 1991, Nephron.
[14] R. Falk,et al. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] J. Velosa,et al. Risk factors in idiopathic renal vasculitis and glomerulonephritis. , 1989, Kidney international.
[16] W. Couser. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.